Published in Br J Cancer on June 16, 2009
The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. Int J Cancer (2011) 1.38
Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. Br J Cancer (2012) 1.34
Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings. AIDS Res Treat (2012) 1.21
The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine (2013) 1.18
Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan. Br J Cancer (2010) 1.10
Cervical cancer risk factors among HIV-infected Nigerian women. BMC Public Health (2013) 1.07
A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria. Infect Agent Cancer (2011) 0.98
Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infect Agent Cancer (2010) 0.96
Differences in the risk of cervical cancer and human papillomavirus infection by education level. Br J Cancer (2009) 0.95
Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme. BMC Infect Dis (2014) 0.95
Factors affecting the prevalence of strongly and weakly carcinogenic and lower-risk human papillomaviruses in anal specimens in a cohort of men who have sex with men (MSM). PLoS One (2013) 0.93
Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial. BMC Infect Dis (2013) 0.90
Integrating cervical cancer screening with HIV care in a district hospital in Abuja, Nigeria. Niger Med J (2013) 0.89
Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis. PLoS One (2015) 0.89
Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Côte d'Ivoire, 2010. Br J Cancer (2012) 0.87
Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies. BMC Infect Dis (2013) 0.86
Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer. Virology (2013) 0.85
Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide. J Virol (2015) 0.84
Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa. J Acquir Immune Defic Syndr (2016) 0.84
Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities. Infect Agent Cancer (2016) 0.84
Human papillomavirus 45 genetic variation and cervical cancer risk worldwide. J Virol (2014) 0.83
Prevalence and predictors of Cervical Intraepithelial Neoplasia among HIV infected women at Bugando Medical Centre, Mwanza-Tanzania. Infect Agent Cancer (2013) 0.82
High prevalence and genotypic diversity of the human papillomavirus in Amazonian women, Brazil. Infect Dis Obstet Gynecol (2013) 0.79
Correlation between ebv co-infection and HPV16 genome integrity in Tunisian cervical cancer patients. Braz J Microbiol (2012) 0.79
Prevalence of HPV infection and other risk factors in a Fijian population. Infect Agent Cancer (2014) 0.78
Plasma cytokine levels and human papillomavirus infection at the cervix in rural Nigerian women. Cytokine (2013) 0.78
Population-based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women. Int J Cancer (2012) 0.78
Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme. BMC Infect Dis (2016) 0.77
Past and future of prophylactic ablation of the cervical squamocolumnar junction. Ecancermedicalscience (2015) 0.76
Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and Africa. Infect Agent Cancer (2017) 0.75
Cervical cancer screening program in Thimphu, Bhutan: population coverage and characteristics associated with screening attendance. BMC Womens Health (2014) 0.75
The Prevalence of HIV in Cancer Patients at the Surgical Oncology Unit of Donka University Hospital of Conakry (Guinea). J Cancer Epidemiol (2015) 0.75
Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria. Infect Agent Cancer (2017) 0.75
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer (2007) 10.29
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis (2007) 6.86
Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer (2006) 5.87
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol (2002) 5.63
A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol (2008) 4.43
Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer (2006) 3.38
Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer (2000) 2.86
Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer (2007) 2.36
Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33
Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer (2004) 2.33
Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Clin Infect Dis (2007) 2.00
Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer (1995) 2.00
Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer (2006) 1.83
Papillomavirus infection in rural women in southern India. Br J Cancer (2005) 1.79
Human papillomavirus genotypes in rural Mozambique. Lancet (2001) 1.69
Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. J Infect Dis (1999) 1.64
A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Gynecol Oncol (2008) 1.63
Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst (2000) 1.62
Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer (2006) 1.62
Distribution of human papillomavirus in a family planning population in nairobi, kenya. Sex Transm Dis (2003) 1.60
The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol (2004) 1.55
Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age. Int J Cancer (2003) 1.46
Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer (2007) 1.45
Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co-infection on HPV genotype distribution. J Med Virol (2004) 1.42
Comparison of non-invasive sampling methods for detection of HPV in rural African women. Sex Transm Infect (2005) 1.22
HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer (2000) 1.19
Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. Br J Cancer (2005) 1.18
Cancer incidence in Conakry, Guinea: first results from the Cancer Registry 1992-1995. Int J Cancer (1997) 1.14
Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention. Int J Cancer (2008) 1.05
Papillomavirus vaccines in perspective. Lancet (2007) 1.05
Prophylactic HPV vaccines: new interventions for cancer control. Vaccine (2008) 1.01
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83
Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer (2003) 4.40
Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene (2006) 2.56
Epidemiology of biliary tract cancers: an update. Ann Oncol (2008) 2.51
Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet (2001) 2.35
Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33
Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer (2006) 2.27
Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer (2002) 2.25
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14
A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control (1999) 2.08
Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect (2002) 2.05
Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol (2006) 2.02
Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer (2009) 1.95
Fish consumption and cancer risk. Am J Clin Nutr (1999) 1.94
The epidemiology of endometrial cancer. Gynecol Oncol (1991) 1.94
Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J Natl Cancer Inst (1998) 1.91
Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer (2007) 1.87
"Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet (1984) 1.87
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer (2010) 1.86
Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer (2006) 1.83
Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers. J Immunol (2000) 1.83
Family history and the risk of stomach and colorectal cancer. Cancer (1992) 1.83
Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83
Papillomavirus infection in rural women in southern India. Br J Cancer (2005) 1.79
Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann Oncol (2013) 1.77
A case-control study of diabetes mellitus and cancer risk. Br J Cancer (1994) 1.76
Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer (2001) 1.75
Classic kaposi sarcoma: epidemiology and risk factors. Cancer (2000) 1.74
Epidemiology of bladder cancer in Alexandria, Egypt: tobacco smoking. Int J Cancer (1997) 1.71
A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control (2000) 1.70
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer (2008) 1.70
Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol (2000) 1.69
Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer (1997) 1.68
The role of reproductive and menstrual factors in cancer of the breast before and after menopause. Eur J Cancer (1996) 1.67
Genital warts and cervical neoplasia: an epidemiological study. Br J Cancer (1983) 1.65
Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol (1996) 1.64
Oestrogens and obesity as risk factors for endometrial cancer in Italy. Int J Epidemiol (1982) 1.64
CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol (2004) 1.63
Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer (2006) 1.62
Olive oil, other dietary fats, and the risk of breast cancer (Italy). Cancer Causes Control (1995) 1.61
Sexual factors, venereal diseases, and the risk of intraepithelial and invasive cervical neoplasia. Cancer (1986) 1.61
The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer (1996) 1.61
Apoptosis in myocardial ischaemia and infarction. J Clin Pathol (2002) 1.59
Cancer of the oral cavity and pharynx in nonsmokers who drink alcohol and in nondrinkers who smoke tobacco. J Natl Cancer Inst (1998) 1.58
Prognostic factors of malignant mesothelioma of the pleura. Cancer (1993) 1.58
Evidence of HTLV-II infection in Guinea, West Africa. J Acquir Immune Defic Syndr (1993) 1.57
Human papillomavirus and HPV vaccines: a review. Bull World Health Organ (2007) 1.55
The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol (2004) 1.55
Risk factors for myocardial infarction in young women. Am J Epidemiol (1987) 1.55
Alcohol consumption and risk of breast cancer: a multicentre Italian case-control study. Eur J Cancer (1998) 1.54
Loss and/or formation of antioxidants during food processing and storage. Cancer Lett (1997) 1.54
Epidemiology and prevention of oral cancer. Oral Oncol (1997) 1.53
HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications. Br J Cancer (2012) 1.53
Food groups and risk of oral and pharyngeal cancer. Int J Cancer (1998) 1.51
Early diagnosis and prevention of sporadic colorectal cancer. Endoscopy (2001) 1.51
Incessant ovulation and ovarian cancer: a critical approach. Int J Epidemiol (1983) 1.51
C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion. Eur J Clin Invest (2004) 1.50
Clinical validation of the cobas 4800 HPV test for cervical screening purposes. J Clin Microbiol (2011) 1.47
Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol (2006) 1.46
A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control (1999) 1.45
Risk factors for endometrioid, mucinous and serous benign ovarian cysts. Int J Epidemiol (1989) 1.45
Long-term impact of reproductive factors on cancer risk. Int J Cancer (1993) 1.45
The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol (2008) 1.44
Height and breast cancer risk. Eur J Cancer (1998) 1.44
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. Br J Cancer (2006) 1.43
A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm). Br J Dermatol (2004) 1.43
Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer (2001) 1.42
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer (2012) 1.41
Oral hygiene, dentition, sexual habits and risk of oral cancer. Br J Cancer (2000) 1.41
Dietary factors and the risk of endometrial cancer. Cancer (1993) 1.41
Occupation and soft-tissue sarcoma in northeastern Italy. Cancer Causes Control (1992) 1.41